about
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the ...
Read More
3.62
-0.08
(-2.16%)
204.0K
XNAS Volume
XNAS 28 Jan, 2026 4:30 PM (EST)
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
X4 Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..